» Articles » PMID: 26807296

Doppler Imaging of Orbital Vessels in the Assessment of the Activity and Severity of Thyroid-associated Orbitopathy

Overview
Journal J Ultrason
Date 2016 Jan 26
PMID 26807296
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with symptoms of thyroid-associated orbitopathy are classified on the basis of the clinical activity score (CAS) proposed by Mourits in 1989. Despite its undoubted clinical usefulness, it has several limitations which can decide about the success or failure of the implemented treatment. Numerous reports mention the presence of hemodynamic changes in orbital and bulbar vessels in the course of an orbitopathy called Graves' disease. The usage of Doppler sonography in the diagnosis of numerous ophthalmologic vascular diseases suggests that changes in thyroid-associated orbitopathy can correlate with the activity and severity of the disease. This paper presents the overview of the state-of-the-art concerning the usefulness of Doppler imaging in patient selection for the treatment of thyroid-associated orbitopathy. It has been shown that the velocity of blood flow in the superior ophthalmic vein, which is the most susceptible to changes in anatomical conditions in the enclosed orbital space, decreases in a statistically significant way. A decrease in blood flow velocity is closely associated with the active stage of the disease whereas reverse flow or its absence attest to severe orbitopathy and constitute a risk factor of ocular neuropathy. The activity of the inflammatory process in the eyeball is also confirmed by an increase in peak systolic velocity (PSV) in the ophthalmic artery and central retinal artery as well as end-diastolic velocity (EDV) in the ophthalmic artery. Resistance index values decrease in the ophthalmic artery and increase in the central retinal artery mainly in cases with considerable expansion of the extraocular muscles.

Citing Articles

Quantifying anterior segment vascular changes in thyroid eye disease using optical coherence tomography angiography.

Masoumi A, Afshar P, Fakhredin H, Ghanbari H, Montazeri F, Aghajani A BMC Med Imaging. 2025; 25(1):85.

PMID: 40069673 PMC: 11899867. DOI: 10.1186/s12880-025-01627-y.


Orbital decompression improves visual function and macular blood perfusion status in patients with thyroid-related eye disease.

Wu B, Zhu M, Zhang F, Cao J, Xie B, Zhu Z Front Med (Lausanne). 2024; 11:1455226.

PMID: 39529797 PMC: 11552090. DOI: 10.3389/fmed.2024.1455226.


In Vitro Investigation of HIF-1α as a Therapeutic Target for Thyroid-Associated Ophthalmopathy.

Lee J, Lee J, Baek H, Lim D, Lee S, Lee J Endocrinol Metab (Seoul). 2024; 39(5):767-776.

PMID: 39410849 PMC: 11525702. DOI: 10.3803/EnM.2024.1952.


A Comparison of Observational Studies on Subfoveal Choroidal Thickness Measured with OCT according to the Level of Thyroid Eye Disease Activity-Systematic Review and Meta-Analysis.

Kowalik-Jagodzinska M, Sobol M, Turno-Krecicka A J Clin Med. 2023; 12(14).

PMID: 37510836 PMC: 10380986. DOI: 10.3390/jcm12144720.


Analysis of macular blood flow changes in thyroid associated ophthalmopathy.

Zhang X, Liu W, Zhang Z, Dai J, Zhang J, Lin L BMC Ophthalmol. 2022; 22(1):501.

PMID: 36539754 PMC: 9764508. DOI: 10.1186/s12886-022-02716-0.


References
1.
Kaiser H, Schoetzau A, Stumpfig D, Flammer J . Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma. Am J Ophthalmol. 1997; 123(3):320-7. DOI: 10.1016/s0002-9394(14)70127-8. View

2.
Alp M, Ozgen A, Can I, Cakar P, Gunalp I . Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation. Br J Ophthalmol. 2000; 84(9):1027-30. PMC: 1723625. DOI: 10.1136/bjo.84.9.1027. View

3.
Mourits M, Koornneef L, Wiersinga W, Prummel M, Berghout A, van der Gaag R . Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989; 73(8):639-44. PMC: 1041835. DOI: 10.1136/bjo.73.8.639. View

4.
Kurioka Y, Inaba M, Kawagishi T, Emoto M, Kumeda Y, Inoue Y . Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy. Eur J Endocrinol. 2001; 144(2):99-107. DOI: 10.1530/eje.0.1440099. View

5.
Perros P, CROMBIE A, Matthews J, Kendall-Taylor P . Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf). 1993; 38(4):367-72. DOI: 10.1111/j.1365-2265.1993.tb00516.x. View